SCHEMBL7755404

SCHEMBL7755404

CCCCCc1cc(O)c2c(c1)OC(C)(C)[C@@H]1CCC(=O)C[C@@H]21

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ CNR2 P34972 12/20 0.72
▸ CNR1 P21554 8/20 0.69
▸ NR1I2 O75469 2/20 0.69
▸ ADORA3 P0DMS8 1/20 0.69
▸ SLC6A3 Q01959 1/20 0.69
▸ ABHD12 Q8N2K0 3/20 0.64
▸ ABHD6 Q9BV23 3/20 0.64
▸ FAAH O00519 2/20 0.64
▸ LDHA P00338 1/20 0.64
▸ GLRA1 P23415 1/20 0.64
▸ GPR183 P32249 1/20 0.64
▸ DRD3 P35462 1/20 0.64
▸ ENPP2 Q13822 1/20 0.64
▸ GPR18 Q14330 1/20 0.64
▸ TRPM8 Q7Z2W7 1/20 0.64
▸ GPR55 Q9Y2T6 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11455743 1.00 CNR2 (0.72) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL11541884 1.00 CNR2 (0.72) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL31545381 1.00 CNR2 (0.72) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL15558108 1.00 CNR2 (0.72) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL16922165 1.00 CNR2 (0.72) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL11787625 0.99 CNR2 (0.71) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL11612711 0.99 CNR2 (0.71) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL11444967 0.99 CNR2 (0.71) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL11616468 0.99 CNR2 (0.71) CNR2CNR1NR1I2ADORA3SLC6A3
SCHEMBL11616464 0.99 CNR2 (0.71) CNR2CNR1NR1I2ADORA3SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250090554-A1 A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION MYND LIFE SCIENCES INC (CA) 2025-03-20 — — US disclosed
US-9347961-B2 Test kit for the quantitative determination of narcotic drugs CHIRON AS (NO) 2016-05-24 — — US disclosed
US-20150204893-A1 TEST KIT FOR THE QUANTITATIVE DETERMINATION OF NARCOTIC DRUGS CHIRON AS (NO) 2015-07-23 — — US disclosed
EP-0597333-B1 Compounds for fluoroscense polarization immunoassays and immunoassays utilising them HOFFMANN LA ROCHE (CH) 2001-02-28 — — EP disclosed
US-5315015-A Compounds having improved fluorescence in fluorescence polarization immunoassays and immunoassays utilizing same HOFFMANN-LA ROCHE INC. (US) 1994-05-24 — — US disclosed
EP-0597333-A2 Compounds for fluoroscense polarization immunoassays and immunoassays utilising them F. HOFFMANN-LA ROCHE AG (CH) 1994-05-18 — — EP disclosed
US-4148809-A Process for preparing dl-cis-1-hydroxy-3-substituted-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-ones ELI LILLY AND COMPANY (US) 1979-04-10 — — US disclosed
US-4054582-A Process for converting cis-hexahydrodibenzo[b,d]pyran-9-ones to trans-hexahydrodibenzo[b,d]-pyran-9-ones ELI LILLY AND COMPANY (US) 1977-10-18 — — US disclosed
Send feedback